Nanotechnology-based chemotherapeutics and imaging agents represent a new era of
“cancer nanomedicine” working to deliver versatile payloads with favorable …

To integrate multiple diagnostic and therapeutic strategies on a single particle through
simple and effective methods is still challenging for nanotheranostics. Herein, we develop …

Biological molecules such as DNA, proteins, and lipids can be assembled into naturally
existing nanoparticles, such as bacterial viruses (also called bacteriophages or phages) …

Hepatocellular carcinoma (HCC) is an epidemic burden and remains highly prevalent
worldwide. The significant mortality rates of HCC are largely due to the tendency of late …

Over the last few years, progress has been made across the nanomedicine landscape, in
particular, the invention of contemporary nanostructures for cancer diagnosis and …

Most hypoxic tumors are insensitive to radiation, which is a major obstacle in the
development of conventional radiotherapy for tumor treatment. Some drugs, such as …

Theranostics has emerged in recent years to provide an efficient and safer alternative in
cancer management. This review presents an updated description of nanotheranostic …

Introduction: Effective therapy of various neurological disorders is hindered on account of
the failure of various therapeutics crossing blood-brain-barrier (BBB). Nanotheranostics has …

Nanotheranostics have demonstrated the development of advanced platforms that can
diagnose brain cancer at early stages, initiate first-line therapy, monitor it, and if needed …

Nanomedicine formulations aim to improve the biodistribution and the target site
accumulation of systemically applied (chemo-) therapeutics. Various different passively and …